News
-
712Heart Attack Risk Peaks in winter
Winter season brings several health worries in its wake including ailments associated with cold, increase in asthma attacks or other pulmonary diseases....
- 847
Fortis Escorts Heart Institute (FEHI) performs Heart Transplant to save life of 16 year old boy
In yet another milestone achievement, Fortis Escorts Heart Institute (FEHI), India’s leading cardiac care facility, under the guidance of Dr Ashok Seth,...
- 913
E-Cigarettes Can Churn Out High Levels Of Formaldehyde
Vapor produced by electronic cigarettes can contain a surprisingly high concentration of formaldehyde — a known carcinogen — researchers reported. The findings,...
- 914
Research suggests possible HIV risk with birth control shot
Researchers conducted a meta-analysis of 18 studies measuring rates of HIV infection among women using hormonal forms of contraception in sub-Saharan Africa. Individual participant data (IPD) was available...
- 592
Himachal to get three Medical Colleges
Himachal Pradesh Chief Minister Virbhadra Singh Saturday said the state would open three medical colleges and one of them would be located in Hamirpur district. Addressing a...
- 777
Spinal Cord Injuries (SCI) on the Rise, Prevention the Only Way Forward
With the rising number of accidents in the country, there has been a significant increase in the number of spinal cord injuries...
- 874
ACCESS Health International Appoints Siddhartha Bhattacharya to Lead ACCESS Health India
ACCESS Health International announced the appointment of Siddhartha Bhattacharya to head ACCESS Health India. In his new role, Bhattacharya will oversee and...
- 698
Kimaya, one screen solution to reduce neonatal deaths
Neonatal deaths accounts for 41% of global deaths among children below five years of age. Despite a reduction of 33% of neonatal...
-
Healthcare sector needs $3 trillion in 10 years: Report
India’s economic growth will not be sustainable unless there is heightened investment on the country’s healthcare that would require injection of USD...
-
Novo Nordisk launches Ryzodeg for diabetes in India
Denmark based pharmaceutical firm Novo Nordisk launchedit’s combination diabetic drugRyzodeg, priced at Rs 1,595 for 300 units, for people with type II diabetes in...
